| abstract |
The present invention relates to the compound 1,1'-adipoylbis (pyrrolidine-2-carboxylate) of (2R, 2'R) -Bis ((((((tetrahydro-2H-piran-4-yl) oxy) carbonyl) oxy ) methyl), pharmaceutical compositions comprising the same and the use thereof for the treatment of diseases or disorders in which the decrease of the P component of serum amyloid (SAP) would be beneficial, including amyloidosis, disease of Alzheimer's disease, type 2 diabetes mellitus and osteoarthritis. |